Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
131.87
-3.47 (-2.56%)
Nov 10, 2026, 10:44 AM EST - Market open

Twist Bioscience Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
118.38110.72103.799.0196.0692.7988.7184.7181.4675.371.566.9563.7460.1854.2457.3156.1148.1342.0237.95
Revenue Growth (YoY)
23.23%19.31%16.89%16.88%17.91%23.23%24.08%26.53%27.81%25.13%31.81%16.82%13.59%25.04%29.09%51.00%60.24%54.23%49.21%17.02%
Cost of Revenue
55.9253.5949.7348.1744.7646.7745.8746.4846.1944.4242.5442.4241.8541.6729.4431.5930.9729.7127.0622.5
Gross Profit
62.4557.1253.9750.8451.346.0342.8438.2335.2730.8828.9624.5221.918.5124.825.7225.1418.4114.9615.45
Selling, General & Admin
80.7176.0969.7463.7663.3763.6756.1853.1456.7955.6252.8447.3946.0653.9742.3254.1653.695451.138.24
Research & Development
18.0319.717.1317.0118.0523.9221.3121.1322.4724.1523.123.7524.5327.3831.2429.6136.8431.2322.6319.44
Operating Expenses
98.7395.7886.8780.7781.4287.5977.4874.2879.2679.7775.9471.1470.5981.3473.5783.7790.5385.2373.7357.69
Operating Income
-36.28-38.66-32.9-29.93-30.12-41.56-34.64-36.04-43.99-48.89-46.98-46.62-48.69-62.83-48.77-58.05-65.39-66.82-58.77-42.23
Interest Expense
------------0-0-0-0-0.03--0.03-0.03-0.08
Interest & Investment Income
1.51.712.182.632.692.83.243.623.663.944.123.893.973.463.041.930.720.260.150.06
Other Non Operating Income (Expenses)
0.040.180.470.42-0.84-0.39-0.09-2.33-0.12-0.2-0.03-0.250.04-0.31-0.160.63-0.23-0.25-0.160.31
EBT Excluding Unusual Items
-34.74-36.77-30.25-26.88-28.27-39.15-31.5-34.75-40.45-45.15-42.89-42.97-44.68-59.68-45.88-55.52-64.9-66.83-58.79-41.95
Merger & Restructuring Charges
------------0.33-9.05-------
Gain (Loss) on Sale of Assets
----48.85----------4.61----0
Asset Writedown
---------44.93---3.17-3.62-------
Legal Settlements
--7.21------------------
Other Unusual Items
------------0.581.24.140.094.236.012.831.05
Pretax Income
-34.74-43.98-30.25-26.8820.58-39.15-31.5-34.75-85.38-45.15-42.89-46.47-56.77-58.48-41.75-50.82-60.67-60.82-55.97-40.9
Income Tax Expense
0.310.040.250.260.190.180.1-0.10.190.350.12-0.220.620.680.080.29-0.15-0.15-10.410.34
Net Income
-35.05-44.02-30.51-27.1420.39-39.33-31.59-34.66-85.57-45.49-43.01-46.24-57.4-59.16-41.82-51.12-60.52-60.67-45.56-41.24
Net Income to Common
-35.05-44.02-30.51-27.1420.39-39.33-31.59-34.66-85.57-45.49-43.01-46.24-57.4-59.16-41.82-51.12-60.52-60.67-45.56-41.24
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
6262616060605959585857575757565656535049
Shares Outstanding (Diluted)
6262616061605959585857575757565656535049
Shares Change (YoY)
2.03%3.44%3.24%3.19%5.19%3.24%2.90%2.23%1.93%1.76%1.87%1.80%1.34%6.18%13.09%14.02%14.96%9.78%8.50%10.21%
EPS (Basic)
-0.56-0.71-0.50-0.450.34-0.66-0.53-0.59-1.47-0.79-0.75-0.81-1.01-1.04-0.74-0.91-1.08-1.13-0.91-0.84
EPS (Diluted)
-0.56-0.71-0.50-0.450.33-0.66-0.53-0.59-1.47-0.79-0.75-0.81-1.01-1.04-0.74-0.91-1.08-1.13-0.91-0.84
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-8.65-25.45-34.79-24.24-10.57-17.13-23.7-17.32-7.34-20.03-24.48-23.1-27.92-53.34-65.89-17.73-74.77-74.31-59.44-42.89
Free Cash Flow Per Share
-0.14-0.41-0.57-0.40-0.17-0.29-0.40-0.30-0.13-0.35-0.43-0.40-0.49-0.94-1.17-0.32-1.33-1.39-1.19-0.87
Gross Margin
52.76%51.59%52.05%51.35%53.40%49.60%48.29%45.13%43.30%41.01%40.51%36.63%34.35%30.76%45.72%44.88%44.80%38.26%35.61%40.72%
Operating Margin
-30.65%-34.92%-31.73%-30.23%-31.36%-44.79%-39.05%-42.55%-54.00%-64.92%-65.70%-69.63%-76.39%-104.41%-89.90%-101.29%-116.54%-138.83%-139.86%-111.28%
Profit Margin
-29.61%-39.76%-29.42%-27.41%21.23%-42.38%-35.61%-40.91%-105.04%-60.41%-60.15%-69.08%-90.05%-98.30%-77.11%-89.20%-107.85%-126.06%-108.44%-108.67%
Free Cash Flow Margin
-7.31%-22.98%-33.55%-24.48%-11.00%-18.46%-26.71%-20.45%-9.01%-26.59%-34.24%-34.50%-43.80%-88.64%-121.48%-30.94%-133.24%-154.40%-141.45%-113.02%
EBITDA
-29.8-32.44-27.01-26.03-24.36-35.36-28.56-31.99-35.69-40.59-38.81-39.02-40.2-55.81-43.47-53.09-60.95-62.85-55.62-39.8
EBITDA Margin
-25.18%-29.30%-26.04%-26.29%-25.36%-38.10%-32.20%-37.76%-43.81%-53.90%-54.28%-58.28%-63.07%-92.73%-80.14%-92.65%-108.62%-130.59%-132.36%-104.88%
D&A For EBITDA
6.486.215.893.95.776.26.084.068.38.38.177.68.497.035.294.954.443.973.152.43
EBIT
-36.28-38.66-32.9-29.93-30.12-41.56-34.64-36.04-43.99-48.89-46.98-46.62-48.69-62.83-48.77-58.05-65.39-66.82-58.77-42.23
EBIT Margin
-30.65%-34.92%-31.73%-30.23%-31.36%-44.79%-39.05%-42.55%-54.00%-64.92%-65.70%-69.63%-76.39%-104.41%-89.90%-101.29%-116.54%-138.83%-139.86%-111.28%
Effective Tax Rate
----0.93%---------------
SEC Filings: 10-K · 10-Q